At the end of the latest market close, IDEXX Laboratories Inc. (IDXX) was valued at $412.13. In that particular session, Stock kicked-off at the price of $415.00 while reaching the peak value of $417.765 and lowest value recorded on the day was $409.98. The stock current value is $416.53.Recently in News on November 1, 2022, IDEXX Laboratories Announces Third Quarter Results. Achieves third quarter revenue growth of 4% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 5% reported and 9% organic, building on high prior year growth. You can read further details here
IDEXX Laboratories Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $656.31 on 01/03/22, with the lowest value was $317.06 for the same time period, recorded on 10/13/22.
IDEXX Laboratories Inc. (IDXX) full year performance was -32.82%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, IDEXX Laboratories Inc. shares are logging -37.34% during the 52-week period from high price, and 31.37% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $317.06 and $664.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 334884 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the IDEXX Laboratories Inc. (IDXX) recorded performance in the market was -36.74%, having the revenues showcasing 12.21% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 34.21B, as it employees total of 10350 workers.
Market experts do have their say about IDEXX Laboratories Inc. (IDXX)
During the last month, 0 analysts gave the IDEXX Laboratories Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 368.27, with a change in the price was noted +49.66. In a similar fashion, IDEXX Laboratories Inc. posted a movement of +13.54% for the period of last 100 days, recording 534,990 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IDXX is recording 2.93 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.60.
Technical breakdown of IDEXX Laboratories Inc. (IDXX)
Raw Stochastic average of IDEXX Laboratories Inc. in the period of last 50 days is set at 76.70%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.85%. In the last 20 days, the company’s Stochastic %K was 65.89% and its Stochastic %D was recorded 67.30%.
Bearing in mind the latest performance of IDEXX Laboratories Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -36.74%. Additionally, trading for the stock in the period of the last six months notably improved by 13.23%, alongside a downfall of -32.82% for the period of the last 12 months. The shares increased approximately by -2.24% in the 7-day charts and went down by 18.21% in the period of the last 30 days. Common stock shares were driven by 12.21% during last recorded quarter.